SCHEMBL2199744

SCHEMBL2199744

Cc1ccc(C(=O)NCCO)cc1C(=O)c1ccc(Nc2ccc(F)cc2)cc1Cl

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 12/20 0.50
MAPK11 Q15759 10/20 0.50
MAPK13 O15264 9/20 0.50
MAPK12 P53778 9/20 0.50
POLB P06746 2/20 0.45
HPGD P15428 1/20 0.45
HTT P42858 1/20 0.45
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
ALDH1A1 P00352 1/20 0.40
AVPR2 P30518 1/20 0.40
OXTR P30559 1/20 0.40
AVPR1A P37288 1/20 0.40
PPARG P37231 1/20 0.39
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2199475 0.93 MAPK14 (0.47) MAPK14MAPK11MAPK13MAPK12POLB
SCHEMBL2202231 0.91 MAPK13 (0.50) MAPK14MAPK11MAPK13MAPK12POLB
SCHEMBL2198471 0.91 MAPK14 (0.63) MAPK14MAPK11MAPK13MAPK12POLB
SCHEMBL2202867 0.90 MAPK14 (0.56) MAPK14MAPK11MAPK13MAPK12POLB
SCHEMBL2198608 0.90 MAPK14 (0.64) MAPK14MAPK11MAPK13MAPK12POLB
SCHEMBL2200118 0.89 MAPK14 (0.55) MAPK14MAPK11MAPK13MAPK12
SCHEMBL2202412 0.87 MAPK13 (0.54) MAPK14MAPK11MAPK13MAPK12CYP1A2
SCHEMBL2198442 0.87 MAPK13 (0.46) MAPK14MAPK11MAPK13MAPK12POLB
SCHEMBL27634461 0.86 MAPK14 (0.52) MAPK14MAPK11MAPK13MAPK12POLB
SCHEMBL2196558 0.85 MAPK14 (0.48) MAPK14MAPK11MAPK13MAPK12POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1826310-B Novel aminobenzophenone compounds LEO PHARMA AS 2010-07-21 CN claimed
CN-1826310-A Novel aminobenzophenone compounds LEO PHARMA AS (DK) 2006-08-30 CN claimed
US-20060166990-A1 Novel aminobenzophenone compounds LEO PHARMA A/S (DK) 2006-07-27 US claimed
EP-1658263-B9 NOVEL AMINOBENZOPHENONE COMPOUNDS LEO PHARMA AS (DK) 2011-11-09 EP disclosed
US-7977387-B2 Aminobenzophenone compounds LEO PHARMA A/S (DK) 2011-07-12 US disclosed
US-7977387-B2 Aminobenzophenone compounds LEO PHARMA A/S (DK) 2011-07-12 US disclosed
US-7977387-B2 Aminobenzophenone compounds LEO PHARMA A/S (DK) 2011-07-12 US disclosed
CN-1826310-B Novel aminobenzophenone compounds LEO PHARMA AS 2010-07-21 CN disclosed
EP-1658263-B1 NOVEL AMINOBENZOPHENONE COMPOUNDS LEO PHARMA AS (DK) 2010-06-02 EP disclosed
CN-1826310-A Novel aminobenzophenone compounds LEO PHARMA AS (DK) 2006-08-30 CN disclosed
US-20060166990-A1 Novel aminobenzophenone compounds LEO PHARMA A/S (DK) 2006-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060166990-A1 Novel aminobenzophenone compounds NFKBIA, UACA, ALDH7A1 MAPK14 697/4885MAPK11 612/4885MAPK13 1063/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.